Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) in Adults Aged 18 Years and Above
Clinical trial NCT05164731 · UNKNOWN
Trial details
- NCT number
- NCT05164731
- Sponsor
- Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-16
- Primary completion
- 2022-08-30
- Enrollment
- 880
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.